Postbiotics of Marine Origin and Their Therapeutic Application
Marine Drugs · 2025
DOI: 10.3390/md23090335 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2025. Verfasst von Isabel M Cerezo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Microbiología, Facultad de Ciencias, Instituto Andaluz de Biotecnología y Desarrollo Azul (IBYDA), CEIMAR, Universidad de Málaga, Cam…. Hauptthemen laut MEDLINE: Aquatic Organisms, Probiotics, Bacteria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The increase in antibiotic-resistant pathogens has prompted the search for alternative therapies. One such alternative is the use of probiotic microorganisms. However, growing interest is now turning toward postbiotics—non-viable microbial cells and/or their components or metabolites—that can confer health benefits without the risks associated with administering live microbes. Marine ecosystems, characterized by extreme and diverse environmental conditions, are a promising yet underexplored source of microorganisms capable of producing unique postbiotic compounds. These include bioactive peptides, polysaccharides, lipoteichoic acids, and short-chain fatty acids produced by marine bacteria. Such compounds often exhibit enhanced stability and potent biological activity, offering therapeutic potential across a wide range of applications. This review explores the current knowledge on postbiotics of marine origin, highlighting their antimicrobial, anti-inflammatory, immunomodulatory, and anticancer properties. We also examine recent in vitro and in vivo studies that demonstrate their efficacy in human and animal health. Some marine bacteria that have been studied for use as postbiotics belong to the genera Bacillus, Halobacillus, Halomonas, Mameliella, Shewanella, Streptomyces, Pseudoalteromonas, Ruegeria, Vibrio, and Weissella. In conclusion, although the use of the marine environment as a source of postbiotics is currently limited compared to other environments, studies conducted to date demonstrate its potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Microbiología, Facultad de Ciencias, Instituto Andaluz de Biotecnología y Desarrollo Azul (IBYDA), CEIMAR, Universidad de Málaga, Campus Universitario de Teatinos s/n, 29071 Málaga, Spain.
- Departamento de Biología y Geología, Escuela Superior de Ingeniería, CEIMAR, Universidad de Almería, 04120 La Cañada de San Urbano, Spain.
ORCID-Profile: Isabel M Cerezo, Olivia Pérez-Gómez, Sonia Rohra-Benítez, Marta Domínguez-Maqueda, Jorge García-Márquez, Salvador Arijo
Zitieren
APA
Cerezo, I. M., Pérez-Gómez, O., Rohra-Benítez, S., Domínguez-Maqueda, M., García-Márquez, J., & Arijo, S. (2025). Postbiotics of Marine Origin and Their Therapeutic Application. Marine Drugs. https://doi.org/10.3390/md23090335
Vancouver
Cerezo IM, Pérez-Gómez O, Rohra-Benítez S, Domínguez-Maqueda M, García-Márquez J, Arijo S. Postbiotics of Marine Origin and Their Therapeutic Application. Marine Drugs. 2025. doi:10.3390/md23090335
BibTeX
@article{Cerezo2025,
author = {Cerezo, Isabel M and Pérez-Gómez, Olivia and Rohra-Benítez, Sonia and Domínguez-Maqueda, Marta and García-Márquez, Jorge and Arijo, Salvador},
title = {Postbiotics of Marine Origin and Their Therapeutic Application},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23090335}
}
EUVIMED